How a simple microfluidic device is automating the quest for safer blood transfusions.
By Science Innovation Team | August 20, 2023
Every two seconds, someone in the United States needs a blood transfusion. This lifesaving gift, collected from generous donors, doesn't go straight from arm to arm. It's processed, separated, and stored in blood banks—a critical logistical marvel that keeps our medical system running. But here's a catch few people know about: red blood cells (RBCs) stored in a blood bank refrigerator slowly deteriorate. This aging process, called the "storage lesion," changes their shape and function, potentially reducing their effectiveness after transfusion.
Approximately 21 million blood components are transfused each year in the U.S. alone, making safe storage practices critically important.
For decades, scientists have studied this by painstakingly looking at blood samples under a microscope, a slow and subjective process. But now, a breakthrough is changing the game: a credit-card-sized microfluidic device that acts as a fully automated, high-speed scout, assessing the health of millions of cells in minutes. This isn't just an incremental improvement; it's a paradigm shift that promises to make blood transfusions safer and more effective for everyone.
Imagine a tiny, complex network of channels and chambers etched onto a clear chip, smaller than a postage stamp. This is a microfluidic device, often called a "lab-on-a-chip." Instead of pumping fluids through large beakers and test tubes, scientists can move minuscule amounts of liquid—think droplets smaller than a single tear—through these microscopic canals.
Use incredibly small samples, saving precious reagents
Process thousands of cells per second
Manipulate fluids with exquisite accuracy
Remove human error and bias from analysis
A modern microfluidic "lab-on-a-chip" device used for blood analysis
In the context of blood storage, these devices are perfect for acting as a quality control checkpoint, rapidly inspecting the physical shape of red blood cells, which is a direct indicator of their health.
A healthy, freshly donated red blood cell is a beautiful thing: a plump, biconcave disc, like a donut with a filled-in center. This shape is perfectly evolved to flex and squeeze through the tiniest capillaries in your body to deliver oxygen.
During storage, however, cells undergo metabolic and physical changes. They slowly lose this ideal shape, becoming:
The more a cell morphs away from its natural discocyte shape, the less capable it is of doing its job and the more likely it is to be cleared rapidly by the recipient's body after transfusion. Tracking the percentage of discocytes over time is therefore a powerful way to measure the quality of a stored blood unit.
Progression of red blood cell degradation during storage
Let's explore a hypothetical but representative experiment that demonstrates the power of this new technology.
To automatically quantify the morphological changes in red blood cells from a single donated unit over its 42-day standard storage period.
A tiny drop of blood is taken from the stored bag at weekly intervals. It is diluted in a special saline solution to ensure cells flow one-by-one without clumping.
The diluted sample is placed into a small inlet port on the microfluidic chip.
A small pump pulls the sample into the main channel of the device. The channel is designed to be just wide enough for blood cells to flow in a single, orderly line—a process called hydrodynamic focusing.
As each cell passes through a specific point in the channel, a high-speed camera takes a extremely detailed picture. Simultaneously, a laser is shone on the cell to measure its size and internal complexity via a technique called flow cytometry.
Sophisticated software instantly analyzes each image. It measures dozens of parameters like circularity, diameter, and perimeter to automatically classify each cell into a morphological category.
Within minutes, the system generates a complete report: a count and percentage for each cell type in the sample.
The results would clearly show a compelling story of decay. On Day 1, almost all cells (e.g., 98%) would be healthy discocytes. With each passing week, this percentage would steadily drop, while the populations of echinocytes and other abnormal shapes would rise.
Method | Cells Analyzed | Time Required | Operator Dependent? |
---|---|---|---|
Manual Microscopy | 300 | ~45 minutes | Yes |
Automated Microfluidics | 30,000 | ~3 minutes | No |
Storage Solution | Discocytes (%) | Echinocytes (%) | Morphology Score |
---|---|---|---|
Standard (CPDA-1) | 75.4 | 19.8 | 76.5 |
Experimental (P-Solv) | 88.9 | 9.1 | 89.8 |
This isn't just about counting weird-looking cells. This automated, high-throughput data allows scientists to:
Provides hard, quantitative data on how fast blood degrades
Quickly test new preservative solutions or storage conditions
Screen individual units to ensure patients receive highest-quality blood
Here's a breakdown of the key components needed to run these experiments.
The clear, rubber-like polymer used to make the microfluidic chip itself.
A salt solution that mimics the body's internal environment for sample dilution.
A special buffer solution that flows alongside the sample stream in the chip.
Optional tags for specific proteins on the cell surface.
Image analysis software serves as the brain of the operation. This isn't a physical reagent, but it's essential. It uses complex algorithms to automatically identify, measure, and classify every single cell that passes through the device.
The humble red blood cell's journey from donor to recipient is becoming smarter, thanks to microfluidic technology. By automating the tedious task of cell morphology analysis, these tiny labs-on-chips are providing researchers with an unprecedented volume of high-quality data. This isn't just about efficiency; it's about building a deeper, data-driven understanding of what makes stored blood safe and effective.
The ultimate goal is clear: to ensure that every bag of blood delivered to a patient's bedside is of the highest possible quality. This technology is a powerful step toward a future where blood transfusions are not just lifesaving, but are optimized to be as safe and therapeutic as modern medicine can possibly make them.